Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

Anti-vascular endothelial growth factor (VEGF) therapeutics such as bevacizumab, which are widely used in cancer treatment, commonly leads to hypertension. Moreover, bevacizumab-induced hypertension is associated with improved clinical outcomes in several cancers. We retrospectively analyzed 89 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Naoki, Takahari, Daisuke, Wakatsuki, Takeru, Osumi, Hiroki, Nakayama, Izuma, Matsushima, Tomohiro, Ichimura, Takashi, Ogura, Mariko, Ozaka, Masato, Suenaga, Mitsukuni, Shinozaki, Eiji, Chin, Keisho, Yamaguchi, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880598/
https://www.ncbi.nlm.nih.gov/pubmed/29632638
http://dx.doi.org/10.18632/oncotarget.24635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880598/
https://www.ncbi.nlm.nih.gov/pubmed/29632638
http://dx.doi.org/10.18632/oncotarget.24635

Ejemplares similares